Drug Shortage Report for INTRALIPID 20%
| Report ID | 145481 |
| Drug Identification Number | 02065673 |
| Brand name | INTRALIPID 20% |
| Common or Proper name | Intralipid 20% (Lipid injectable emulsion) 500 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SOYBEAN OIL |
| Strength(s) | 20% |
| Dosage form(s) | EMULSION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500 mL |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-09-07 |
| Actual start date | 2021-09-07 |
| Estimated end date | 2021-10-21 |
| Actual end date | 2021-10-21 |
| Shortage status | Resolved |
| Updated date | 2021-10-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2021-10-22 | English | Compare |
| v6 | 2021-10-21 | French | Compare |
| v5 | 2021-10-21 | English | Compare |
| v4 | 2021-10-07 | French | Compare |
| v3 | 2021-10-07 | English | Compare |
| v2 | 2021-09-10 | French | Compare |
| v1 | 2021-09-10 | English | Compare |
Showing 1 to 7 of 7